BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29113931)

  • 1. Neurobiological Mechanisms of Chemotherapy-induced Cognitive Impairment in a Transgenic Model of Breast Cancer.
    Winocur G; Berman H; Nguyen M; Binns MA; Henkelman M; van Eede M; Piquette-Miller M; Sekeres MJ; Wojtowicz JM; Yu J; Zhang H; Tannock IF
    Neuroscience; 2018 Jan; 369():51-65. PubMed ID: 29113931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of chemotherapy on cognitive function in a mouse model: a prospective study.
    Winocur G; Henkelman M; Wojtowicz JM; Zhang H; Binns MA; Tannock IF
    Clin Cancer Res; 2012 Jun; 18(11):3112-21. PubMed ID: 22467680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats.
    Jiang ZG; Winocur G; Wojtowicz JM; Shevtsova O; Fuller S; Ghanbari HA
    PLoS One; 2018; 13(1):e0191866. PubMed ID: 29370277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.
    Orchard TS; Gaudier-Diaz MM; Weinhold KR; Courtney DeVries A
    Breast Cancer Res Treat; 2017 Feb; 161(3):391-398. PubMed ID: 27933449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats.
    Winocur G; Wojtowicz JM; Huang J; Tannock IF
    Psychopharmacology (Berl); 2014 Jun; 231(11):2311-20. PubMed ID: 24343419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental enrichment protects against cognitive impairment following chemotherapy in an animal model.
    Winocur G; Wojtowicz JM; Merkley CM; Tannock IF
    Behav Neurosci; 2016 Aug; 130(4):428-36. PubMed ID: 27337062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model.
    Winocur G; Binns MA; Tannock I
    Neuropharmacology; 2011 Dec; 61(8):1222-8. PubMed ID: 21803055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memory loss in chemotherapy-treated rats is exacerbated in high-interference conditions and related to suppression of hippocampal neurogenesis.
    Winocur G; Wojtowicz JM; Tannock IF
    Behav Brain Res; 2015 Mar; 281():239-44. PubMed ID: 25529185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer.
    Rendeiro C; Sheriff A; Bhattacharya TK; Gogola JV; Baxter JH; Chen H; Helferich WG; Roy EJ; Rhodes JS
    Behav Brain Res; 2016 Dec; 315():10-22. PubMed ID: 27478140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice.
    Winocur G; Vardy J; Binns MA; Kerr L; Tannock I
    Pharmacol Biochem Behav; 2006 Sep; 85(1):66-75. PubMed ID: 16935324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in mice.
    Walker EA; Foley JJ; Clark-Vetri R; Raffa RB
    Psychopharmacology (Berl); 2011 Oct; 217(4):539-48. PubMed ID: 21537942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of early chemotherapeutic treatment on learning in adolescent mice: implications for cognitive impairment and remediation in childhood cancer survivors.
    Bisen-Hersh EB; Hineline PN; Walker EA
    Clin Cancer Res; 2013 Jun; 19(11):3008-18. PubMed ID: 23596103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
    Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
    Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMF and MET treatment induce cognitive impairment through upregulation of IL-1α in rat brain.
    Alhowail AH; Almogbel YS; Abdellatif AAH; Alsalehi NF; Alghenaim FA; Aldubayan MA; Felemban SG
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4385-4393. PubMed ID: 34227073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline.
    Gault VA; Lennox R; Flatt PR
    Diabetes Obes Metab; 2015 Apr; 17(4):403-13. PubMed ID: 25580570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute treatment with methotrexate induces hippocampal dysfunction in a mouse model of breast cancer.
    Yang M; Kim JS; Kim J; Jang S; Kim SH; Kim JC; Shin T; Wang H; Moon C
    Brain Res Bull; 2012 Oct; 89(1-2):50-6. PubMed ID: 22796103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cognitive function and hippocampal neurogenesis following cancer chemotherapy.
    Christie LA; Acharya MM; Parihar VK; Nguyen A; Martirosian V; Limoli CL
    Clin Cancer Res; 2012 Apr; 18(7):1954-65. PubMed ID: 22338017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
    Ren X; St Clair DK; Butterfield DA
    Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive Impairment.
    Gibson EM; Nagaraja S; Ocampo A; Tam LT; Wood LS; Pallegar PN; Greene JJ; Geraghty AC; Goldstein AK; Ni L; Woo PJ; Barres BA; Liddelow S; Vogel H; Monje M
    Cell; 2019 Jan; 176(1-2):43-55.e13. PubMed ID: 30528430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.